Jeffrey Adam Novack is CLO & Secretary at CareDx, Inc. (CDNA). They have made 3 open-market trades across 1 company since 2024, most recently 2026-10-01.
CIK 0002019976
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDNA | 105,078 | $6.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDNA | SELL · 10b5-1 | 2026-05-05 | 2026-05-06 | $20.68 | $56K | -5.2% | +2.5% | +117.1% |
| CDNA | SELL | 2026-02-03 | 2026-02-04 | $20.56 | $91K | +3.8% | -4.5% | +10.5% |
| CDNA | SELL | 2025-12-04 | 2025-12-05 | $19.16 | $274K | +5.3% | +7.0% | +1.3% |
| CDNA | SELL · 10b5-1 | 2025-11-07 | 2025-11-10 | $15.52 | $42K | -6.6% | +15.8% | +19.6% |
| CDNA | SELL · 10b5-1 | 2025-08-05 | 2025-08-07 | $12.79 | $34K | -4.4% | +10.2% | +36.6% |
| CDNA | SELL · 10b5-1 | 2025-05-05 | 2025-05-07 | $14.70 | $40K | +19.7% | +32.0% | -13.1% |
| CDNA | SELL | 2025-04-07 | 2025-04-09 | $17.72 | $16K | -1.5% | -14.9% | +6.6% |
| CDNA | SELL · 10b5-1 | 2025-02-04 | 2025-02-05 | $23.30 | $164K | +3.7% | -19.9% | -40.0% |
| CDNA | SELL · 10b5-1 | 2024-12-04 | 2024-12-06 | $26.00 | $50K | -17.9% | -6.1% | -23.9% |
| CDNA | SELL · 10b5-1 | 2024-11-18 | 2024-12-03 | $21.99 | $229K | -7.1% | -12.6% | -14.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.